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INTRODUCTION
The local immune response following central nervous system (CNS) damage occurs in different compartments: meninges, ventricles and choroid plexus, perivascular spaces, brain parenchyma, and blood vessels, each involving specialized immune cells. Microglia are myeloid cells that colonize CNS during early embryonic development and persist throughout life. Their ontogeny and transcriptional signature are different from peripheral macrophages (Butovsky et al., 2014; Prinz et al., 2014) . Macrophages residing in the choroid plexus, perivascular and leptomeningeal spaces, called CNS-border associated macrophages (BAMs), originate prenatally in the yolk sac (Goldmann et al., 2016) and form stable populations, except choroid plexus macrophages that exchange with peripheral monocytes (Goldmann et al., 2016) . BAMs are involved in immune surveillance and support entrance of peripheral immune cells into the CNS under pathological conditions (Wehner et al., 2001) . Perivascular macrophages express the mannose receptor CD206 in mice (Galea et al., 2005) and the scavenger receptor CD163 in rats, monkeys, and humans (Fabriek et al., 2005; Kim et al., 2006; Zhang et al., 2011) . Under physiological conditions CD163 is expressed on tissue macrophages, except microglia and some monocytes (Abtin et al., 2014; Jolivel et al., 2015; Kida et al., 1993; Polfliet et al., 2006) and participates in clearance of hemoglobin/haptoglobin complexes and tissue protection from oxidative damage (Onofre et al., 2009) . Many anti-inflammatory signals up-regulate CD163, while pro-inflammatory signals down-regulate its expression (Van Gorp et al., 2010) . BAMs express high MHCII levels and display phagocytic activity (Zhang et al., 2002) . Two recent studies have analysed brain macrophages in mice at the single-cell level and demonstrated a clear segregation of BAMs from microglia, identified a BAM core gene signature and revealed heterogeneity within BAMs (Van Hove et al., 2019; Jordao et al., 2019) .
The role of BAMs in CNS integrity and their functions under pathological conditions are less known. CD163 + cells accumulate in the injured parenchyma after traumatic brain injury and in multiple sclerosis brain lesions (Pey et al., 2014; Zhang et al., 2012 Zhang et al., , 2011 , in encephalitic J o u r n a l P r e -p r o o f Journal Pre-proof lesions in HIV-infected humans and SIV-infected macaques (Fabriek et al., 2005; Filipowicz et al., 2016; Kim et al., 2006) , and contribute to neurovascular dysfunction in Alzheimer's disease and hypertension (Faraco et al., 2016; Park et al., 2017) . In acute cerebral inflammatory reactions, such as those following stroke in mice BAMs produce leukocyte chemoattractants and VEGF as a part of their response to hypoxia, but that study was limited to 24 h postischemia (Pedragosa et al., 2018) . However, the time-course evolution of the phenotype and behaviour of perivascular macrophages in the inflamed brain after stroke is currently unknown.
In this study we investigated the dynamics of BAMs after cerebral ischemia in rodents and humans. RNA sequencing of CD11b + CD163 + cells from ischemic and control brains showed their distinct transcriptomic identity when compared to other brain macrophages and ischemia-induced changes. In mice, CD169 + cells accumulated in the ischemic core 4 days after ischemia. Using Cx3cr1 gfp Ccr2 rfp bone marrow (BM)-chimeric mice we demonstrated that a small fraction of CD169 + BAMs after ischemia are BM-derived cells that accumulate in perivascular spaces and ischemic lesions.
MATERIALS AND METHODS
Adult male Wistar rats weighing 250-300 g were from the Nencki Institute animal facility.
Focal cerebral ischemia was induced by transient (90 min) occlusion of a middle cerebral artery (MCA) as reported (Szydlowska et al., 2006) . Rats were anesthetized with 1.5% isoflurane/oxygen and ischemia was produced using a 0.4 mm nylon suture (DoccolCo., Sharon, MA, USA). After occlusion, the nylon filament was withdrawn to allow reperfusion. In sham-operated animals the right common carotid artery was isolated and the external carotid artery was ligated. Ischemic damage was assessed by measuring neurological deficits in a Bederson four-point scale (Bederson et al., 1986) .
In mice, MCAo was carried out under isoflurane anaesthesia in 30% O 2 and 70% N 2 O as described . Brain ischemia was induced in 3-4 months, 22-30 g male C57BL/6j mice (Charles River, Lyon, France) and transgenic C57BL/6j mice expressing green and red fluorescent reporters from Cx3Cr1 or CCR2 promoters (Cx3Cr1 egfp /CCR2 rfp ).
MCA was occluded using a nylon filament 7-0 (#701912PK5Re, Doccol. Co.,Sharon, MA, USA) for 45 min and later removed to allow reperfusion. Cerebral blood flow was monitored using Doppler imager to ensure MCA occlusion/reperfusion. lysed using 1x lysis buffer for 5 min and washed with DPBS. BM cells (5 x 10 6 ) in 200 µl DPBS were injected through the caudal vein of the tail. Recipient mice reconstituted BM for 2 months before MCAo. Chimerism was evaluated in the blood by flow cytometry.
Tissue processing and immunohistochemistry
Rats were perfused with PBS followed by 4% paraformaldehyde solution in PBS, pH 7.4. Brains were removed and fixed in 4% paraformaldehyde overnight, stored in 30% sucrose, frozen in freezing medium and stored at -80°C. Crytostat sections (14-18 µM) were blocked in normal serum and incubated overnight with primary antibodies followed by secondary antibodies conjugated with fluorophores (Alexa Fluor ® 488 or 555, Molecular probes, Life Technologies, SA). Fluorescent images were acquired with Leica fluorescent microscope and confocal images using Zeiss Cell Observer SD and Leica SP5 microscopes. Antibodies used for immunohistochemistry are listed in the Supplementary Table 1 .
Tissue dissociation and flow cytometry
After neurologic assessment, animals were transcardially perfused with PBS to remove blood.
Brains were removed and stored in HBSS (Hanks buffered saline). Ipsilateral hemispheres were dissected and subjected to mechanical and enzymatic dissociation using neural tissue dissociation kit (Miltenyi Biotec, Bergisch-Gladbach, Germany pictures for each brain region using the ×40 objective in two different sections and an average count was taken as representative for region/subject.
mRNA library preparation and RNA-sequencing
Integrity and quality of RNA were assessed on an Agilent 2100 Bioanalyzer using an RNA 6000
NanoLabChip kit (Agilent Technologies, CA, USA). All RIN values were above, 7, 7.3, 7.4 and 7.7 for sham-operated animals and 7.7, 8.3 and 7.9 for MCAO animals. In total, 6 strandspecific RNA libraries for sequencing were prepared (three biological replicates/treatment) using a KAPA Stranded mRNA Sample Preparation Kit. Poly-A mRNAs were purified from 500 ng of total RNA (extracted from immunosorted CD11b+CD163+ cells) using poly-T-oligo-magnetic beads (KapaBiosystems, MA, USA). mRNAs were fragmented and a first-strand cDNA was synthesized using reverse transcriptase and random hexamers. Second cDNA synthesis was performed by removing RNA templates and synthesizing replacement strands, incorporating dUTP in place of dTTP to generate double-stranded (ds) cDNA. dsDNA was then subjected to the addition of "A" bases to the 3′ ends and ligation of adapters from NEB followed by uracil RNA-seq reads were aligned to rat genome (version rn5) using STAR program (Dobin et al., 2012 Datasets were analysed for differences in individual gene expression (magnitude of fold change, FC), as well as for individual pathways (Gene Ontology). Identification of gene functional groups was performed in R using gProfileR library (Reimand et al., 2016) . Genes that were differentially expressed in terms of their FDR (false discovery rate) corrected p-value were sorted according to their FC values; separate analyses for down-and up-regulated genes were performed on genes with stronger fold change differences.
Statistical analysis
Data were analysed using GraphPad Prism version 6.0. All data are expressed as a mean ± standard error of the mean (SEM). Data were analysed using Student's t test or Mann-Whitney test, or ANOVA (for more than two groups). Differences with p-values <0.05 were considered statistically significant; p-values were adjusted for assessment of multiple comparisons using Sidak's correction.
RESULTS

J o u r n a l P r e -p r o o f
Journal Pre-proof
Accumulation of CD163+ perivascular and meningeal macrophages in response to ischemic injury
In control brains, CD163 + cells were detected close to the basal laminae of the vascular membrane (visualized with Laminin staining). The cells were elongated along brain blood vessels and at the leptomeningeal spaces (Supplement Fig. S1A ). Iba1 + cells in the stroma of the choroid plexus did not express CD163, but the adjacent cells surrounding blood vessels were CD163 + (Supplemental Fig. S1B ). We found increased numbers of CD163 + cells at perivascular spaces and meninges in the ipsilateral hemisphere of ischemic brains when compared to the contralateral site ( Fig. 1A) . One-day post-ischemia, CD163 + and Iba1 + cells had more amoeboid morphology in the ischemic hemispheres (Supplemental Fig. S2A ).
Notably, at day 3 post-ischemia, the number of CD163 + cells increased both at perivascular and meningeal spaces and in the ischemic parenchyma, which suggests migration of CD163 + cells from perivascular spaces ( Fig. 1A ). CD163 + cells were not detected in the brain parenchyma of control rats. We optimized a protocol for effective isolation of CD11b+CD163+ cells using enzymatic tissue dissociation, myelin removal and flow cytometry. Staining with a LIVE/DEAD Violet viability dye demonstrated that >93% of isolated cells were viable. Quantification of CD163 + cells confirmed the observed changes ( Fig. 1B ).
Furthermore, we evaluated the numbers of CD163 + cells in brain (n=6) and blood (n=8) of rats by flow cytometry (gating strategy in supplemental Fig. S1 ). We found 1.340.38% CD163 + cells in the control brain ( Fig. 1B, C) , whereas CD163 + cells were not detected in the blood (0.020.02%) (Supplemental Fig. S1C ). Percentages of CD163 cells showed a significant 5-fold increase in the ischemic brain three days post-ischemia versus controls (Fig. 1C ). 
Transcriptomes of CD163 + cells are distinct from microglia and BM-macrophages
Inflammatory phenotype of CD163 + macrophages in the ischemic brain
Gene Ontology analyses of RNA-seq data show overrepresentation of biological functions associated with immune system processes and wound healing. In particular, genes coding for a transmembrane cytokine of tumor necrosis factor family (TNFRSF9), Osteopontin (Spp1), leukocyte immunoglobulin-like receptor B4 (LILRB4) and macrophage colony stimulating factor 1 (Csf1), Ficolin-B (Fcnb), Galectin 3/Mac-1 (Lgals3) and Thrombospondin-1 (Thbs1) were highly increased in CD163 + cells from ischemic brains when compared to control brains (Fig. 3A ). The Volcano plot shows a number of genes significantly changed after ischemia ( Fig. 3E ). TNFRSF9, SPP1, Galectin 3 and CSF-1 are immunomodulators and may provide chemotactic signals to infiltrating leukocytes. Many of those proteins are playing important roles in in cell-cell adhesion, cell-extracellular matrix interactions, macrophage activation. Notably, CSF-1 regulates macrophage proliferation and differentiation.
The genes from a functional group associated with inflammatory responses including interleukin-6 (Il6), IL-1 receptor antagonist (Il1ra), hypoxia inducible factor-1 (Hif1a), 18 kDa translocator protein (Tspo) and purinergic receptor P2Y2 (P2ry2) were significantly up-regulated in CD163 + cells from ischemic hemispheres (Fig. 3B) . The expression of genes coding for matrix metalloproteinases (MMPs) such as Mmp2, Mmp7, Mmp8, Mmp12, and Mmp14 increased significantly in CD163 + cells after ischemia (Fig. 3C) . In contrast, the expression of genes coding for collagens such as Cola2, Col4a3, Col6a1, Col6a2, Col11a2 and Col20a1 was down-regulated after ischemia (Fig. 3D ).
Genes involved in antigen presentation such as Mrc1 (coding for CD206), RT1-Ha, RT1-M3-1, RT1-CE4, RT1-CE5, RT1-Doa, Cd74 were down-regulated in CD163 + cells 3 days after MCAo, indicating that the antigen presentation capacity of CD163 + cells was impaired after J o u r n a l P r e -p r o o f ischemia (Supplemental Fig. S2C ). Moreover, genes coding for pro-inflammatory cytokines such as Il1a, Il6, and Il23a were up-regulated in CD163 + cells from ischemic hemispheres (Supplemental Fig. S2C ).
Using double immunofluorescence and fluorescent microscopy we found that perivascular and meningeal CD163 + cells in the ischemic hemispheres do not express iNOS ( Fig. 4) . In contrast, CD163 + cells that accumulated in the ischemic parenchyma had strong iNOS expression ( Fig. 4) and undetectable Arg-1 immunoreactivity (data not shown). The observed transcriptional profiles combined with the lack of Arg1 and high iNOS, suggest that CD163 + cells infiltrating the brain parenchyma acquire a pro-inflammatory phenotype similarly to microglia expressing inflammation mediators after ischemic injury (Minutti et al., 2016; Miró-Mur et al., 2015; Shechter et al., 2013) .
CD206 and CD169 antigens identify perivascular and meningeal macrophages in the murine brain
The Figure 5A shows CD206 + cells (also positive for CD169) localised near the vasculature in the mouse brain. CD206, a mannose receptor C type 1 (MRC1) involved in phagocytosis and antigen presentation, is expressed by perivascular macrophages and dendritic cells. Four days after ischemia, perivascular macrophages up-regulated CD206 and CD169 expression, particularly at the periphery of infarction (Fig. 5B ). We did not observe accumulation of CD206 + cells in the ischemic brain parenchyma, where some CD169 + cells were detected 4 days post-ischemia (Fig. 5B ). This finding shows that ischemia induced the presence of CD169 + cells in the brain parenchyma, but it does not inform on whether this effect is due to cell migration or upregulation of CD169 expression by resident microglia.
BM-derived macrophages contribute to the pool of CD169 + cells in the ischemic brain
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Using Cx3cr1 GFP/+ Ccr2 rfp/+ mice we studied features of CD206 + /CD169 + cells in the ischemic tissue. Microglia express high levels of CX3CR1 GFP and are CCR2 RFP negative (Prinz and Priller, 2010; Wolf et al., 2013) , whereas monocytes are mostly CCR2 RFP+ (Saederup et al., 2010) . We found that CD206 + and CD169 + cells in the contralateral hemisphere express low levels of CX3CR1 GFP , and do not express CCR2 RFP (Fig. 6A ), in agreement with the reports that perivascular macrophages express less CX3CR1 than microglia (Faraco et al., 2017; Goldmann et al., 2016) . Four days post-ischemia, we observed CD206 + or CD169 + cells expressing CX3CR1 GFP at perivascular locations. A few CD169 + cells co-localized with CCR2 RFP at the meninges suggesting migration of these cells from the periphery. We also found CX3CR1 GFP CD169 + cells in the brain parenchyma ( Fig. 6B ).
To investigate whether perivascular macrophages in the ischemic murine brain originate from the periphery, we used chimeric mice generated by transplanting bone marrow of Cx3Cr1 gfp/+ Ccr2 rfp/+ donors to recipient wild type mice. Blood chimerism analysed in these mice 4 days post-ischemia compared with the blood from naïve control mice is shown (Supplemental Fig. S3A, S3B) . In chimeric mice, only circulating leukocytes express CX3CR1 GFP and/or CCR2 RFP (Supplemental Fig. S4A, B ). Sham-operated chimeric mice rarely showed CX3CR1 GFP cells in the brain parenchyma, but they showed a few fluorescent cells in the choroid plexus (data not shown), and a few CX3CR1 GFP cells in perivascular spaces. The latter could be due to some degree of artificial inflammation induced by chimera generation. However, four-days postischemia, perivascular and parenchymal CD169 + cells found the infarct core were mostly BMderived CX3CR1 GFP positive cells and some of them expressed low levels of CCR2 RFP (Fig. 7A ) .
Notably, CD169 + cells in the perivascular spaces after ischemia either did not show fluorescence, which indicates that they were CNS resident cells, or showed green fluorescence, indicating that they derive from CX3CR1 + monocytes (Fig. 7A ). Among the subset of CD11b + CD206 + cells and CD11b + CD169 + cells in the ischemic brains, 12% were CX3CR1 dim J o u r n a l P r e -p r o o f cells and only 0.17% were CX3CR1 hi cells (n=10) (Supplemental Fig. S5 ) suggesting that these cells were different from microglia, which express CX3CR1 hi .
We quantified the proportion of BM-derived CD169 + cells using multi-parameter flow cytometry. Living cells were gated based on CD11b + CD169 + expression and analysed according to CX3CR1 GFP and CCR2 RFP expression (Fig. 7B ). The majority (76%) of the CD169 + cells in the brain 4 days post-ischemia were non-fluorescent and therefore corresponded to brain resident cells. However, a fraction of CD169 + cells derived from the BM since amongst the CD169 + cells we found CCR2 RFP+ CX3CR1 GFP+ cells (15.3%) and CCR2 RFP+ CX3CR1 GFPcells (5.7%), whereas CCR2 RFP-CX3CR1 GFP+ cells were infrequent (0.4%) ( Fig. 7C ). CD169 + cells in the blood of ischemic mice were negligible suggesting maturation of peripheral myeloid cells into CD169 + macrophages in the ischemic brain tissue (Fig. 7C ).
CD163+ macrophages accumulate in the human brain parenchyma after stroke
We studied CD163 expression in post-mortem brain tissues of eight stroke patients deceased at different times after stroke. Immunostaining represents CD163 (green) and laminin (red), and ToPro (blue) was used to visualise nuclei. Representative images show meninges and brain parenchyma corresponding to non-ischemic regions or ischemic zones at the indicated times following stroke onset. CD163 + cells were found only in leptomeninges and perivascular spaces of human brains the first day after stroke. Samples obtained from patients 6 to 140 days after stroke showed the presence of CD163 + cells within the infarcted brain parenchyma (Fig. 8A,B) . The unaffected non-ischemic brain region shows elongated CD163 + BAMs. Staining of the tissue samples obtained from patients 5-6 to 140 days after stroke shows accumulation of CD163 + macrophages in the meninges proximal to the ischemic core, and the progressive appearance of amoeboid CD163 + macrophages within the core of the lesion (arrows). Furthermore, stroke increased the numbers of CD163 + cells in the leptomeninges close to the injured tissue, suggesting infiltration of peripheral cells through this pathway (Fig.
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DISCUSSION
CD163+ BAMs having the distinct transcriptional signature proliferate and acquire a pro-inflammatory phenotype in the rat ischemic parenchyma.
The present study provides the first, comprehensive characterization of perivascular and meningeal macrophages in ischemic brains of rats, mice, and stroke patients. Knowledge on functions of non-parenchymal brain macrophages is currently limited, but some studies point to detrimental roles under pathological conditions (Abtin et al., 2014; Jolivel et al., 2015) . CD163 is a typical marker of CNS-border associated macrophages (BAMs) in rat, monkey, and human brain (Kim et al., 2006) . We successfully isolated CD11b + CD163 + cells from rat brains and provided molecular characteristics indicating that these macrophages are a distinct population from microglia and BM-macrophages. Recent single cell RNA sequencing studies revealed a separation of BAMs from parenchymal microglia in mice and led to the identification of a BAM core gene signature (Apoe, Ms4a7, Ms4a6c, Clec4a1) . Thanks to advanced technology those studies showed an unanticipated heterogeneity within BAMs and discrete border-specific cell gene expression profiles (Van Hove et al., 2019) . We found that rat CD163 + cells expressed genes consistent with the proposed BAM core gene signature such as: Clec10a, Apoc1, Apoc4, Cxcr4, Mrc1). After ischemia, CD163 + cells upregulated the expression of genes coding for Metalloproteinases (MMP7, 12, 14) , behaviour. The detection of Ki67 + CD163 + cells by immunofluorescence confirms that CD163 + cells proliferate in the ischemic brain. Accordingly, the expression of Csf1 encoding macrophage colony stimulating factor 1, implicated in proliferation and differentiation of macrophages, was increased.
Using flow cytometry and immunofluorescence we demonstrate that CD163 + cells accumulate in the injured brain 3-4 days following ischemia in rats. CD163 + cells in the ischemic parenchyma were round and large compared to the cells in the contralateral hemisphere. The increased expression of genes coding for metalloproteinases and the reduced expression of genes coding for many collagens indicate that these cells might be involved in degradation of extracellular matrix to facilitate migration into the injured tissue (Fig.3) . Moreover, these cells expressed many inflammatory genes (Tspo, Ilrn, Nlrp, Litaf, Tnfsf9, Tnfrsf21, Ptgs2) . CD163 + cells in the ischemic parenchyma were positive for iNOS, indicative of their pro-inflammatory phenotype. Our results suggest that CD163 + cells migrating into the ischemic brain parenchyma can promote inflammation. Several studies reported the presence of CD163 + cells in the parenchyma during injury or infection (Borda et al., 2008; Pey et al., 2014; Zhang et al., 2012) .
We did not observe CD163 + cells in the brain parenchyma within the first 24 h post-ischemia, in agreement with our previous study (Pedragosa et al., 2018) , but they accumulated in the parenchyma from day 3 post-ischemia. This strengthen our interpretation that proliferating CD163 + cells found in the ischemic brain parenchyma originate, at least in part, from perivascular macrophages.
Owing to a strategic residence at the abluminal side of blood-vessels, CD163 + cells might be involved in presenting antigens to circulating lymphocytes. Studies from MS lesions reported elevated levels of markers associated with antigen presentation such as CD163, DC-SIGN, CD40 and co-stimulatory B7 (Fabriek et al., 2005) . However, we noticed unaltered or J o u r n a l P r e -p r o o f Journal Pre-proof down-regulated expression of genes related to antigen presentation after brain ischemia indicating a disease-specific role of these cells.
4.2.
Resident CD169 + BAMs accumulate in the brain parenchyma in mice, but there is limited replacement with peripheral monocytes in the sub-acute phase of stroke.
We made use of genetic tools available in mice to determine whether BM-derived macrophages contributed to the pool of parenchymal macrophages expressing BAM markers after ischemia. Immunostaining for CD206 and CD169 was used to recognise perivascular macrophages in mice, as CD163 expression is low in this species. CD11b + CD169 + macrophages are a specific cell population and CD169 is considered a marker for activated phagocytes in inflammatory disorders (Bogie et al., 2017; Chavez-Galan et al., 2015) . CD206, a C-type lectin, mannose receptor is expressed by most tissue macrophages, dendritic cells, and specific lymphatic or endothelial cells. We found modulation of CD206 and CD169 expression after the ischemic injury; in particular, CD169 was found in macrophages in the brain parenchyma, where CD206 was not detected.
Under physiological conditions microglia self-renew in a CSF1R-dependent manner (Ginhoux and Guilliams, 2016; Greter et al., 2015) . Proliferation of resident microglia during injury and infection has been reported in rodents (Denes et al., 2007) . The proliferative capacity of CNS-BAMs after ischemia shows that those cells are more similar to microglia in terms of gene expression, origin and maintenance than to BM-derived macrophages (Goldmann et al., 2016) . Using chimeric mice transplanted with BM from transgenic CX3CR1 GFP CCR2 RFP mice, we determined the contribution of peripheral monocytes to the pool of perivascular macrophages in the ischemic brain. In chimeric mice, about 30% of CD169 + macrophages in the ischemic brain originated from infiltrating BM cells expressing fluorescent reporters, while we rarely found CD169 + CCR2 -CX3CR1 low perivascular macrophages in the contralateral hemisphere. Moreover, J o u r n a l P r e -p r o o f Journal Pre-proof most of CD169 + BM-derived macrophages at perivascular locations were CX3CR1 + suggesting that infiltrating CX3CR1 + monocytes may acquire features of perivascular macrophages in the injured tissue. CX3CR1 + monocytes are non-classical monocytes that exert patrolling functions and are associated with wound healing and resolution of inflammation (Thomas et al., 2015) .
Our findings suggest that peripheral patrolling monocytes repopulate the perivascular spaces four days after brain ischemia. The negligible presence of CD169 + cells in the blood after ischemia suggests that infiltrating myeloid cells mature into CD169 + macrophages in the CNS.
The new finding of communicating channels between the skull bone marrow and the leptomeningeal zone opens the possibility for direct migration of BM-macrophages to leptomeningeal and perivascular spaces (Herisson et al., 2018) .
Experimental findings from rodent stroke models are corroborated by the observation showing the progressive accumulation of CD163 + macrophages in the post-mortem human brain tissue starting several days after stroke onset (Fig.8) .
Conclusions
Recent studies revealed considerable heterogeneity of immune infiltrates and raised an urgent question regarding a functional phenotype of cells infiltrating a diseased brain.
Modulation of functions of specific populations of immune cells is currently considered as a novel approach in stroke therapy. A potential effective treatment of stroke depends on our better understanding of molecular events underlying stroke-induced inflammation. CNS-borderassociated macrophages -BAMs encompassing perivascular, meningeal and choroid plexus macrophages was until this year one of the enigmatic population in the central nervous system.
Two recent studies have analyzed brain macrophages in mice at a single-cell level and demonstrated a segregation of BAMs from microglia, a specific "BAM core gene signature" and heterogeneity within BAMs (Van Hove et al., 2019; Jordao et al., 2019) . In both studies BAMs J o u r n a l P r e -p r o o f have been studied under physiological conditions, during EAE and after pharmacological depletion of myeloid cells. Considering well known differences in composition of myeloid infiltrates and functionality of myeloid cells under pathological conditions between mice and rats, we found it important to decipher identity and fates of those cells in rats, mice and humans after stroke.
Summarizing, the data from rat and mouse stroke models and as well as from human stroke patients show dynamics of BAMs in the brain, their proliferation and migration to the ischemic parenchyma several days after stroke onset. In rats, CD163 + BAMs have the different transcriptional signature than microglia and peripheral macrophages. CD163 + cells proliferate. 
